Nasdaq Biotech sank 6.5% in its worst weekly drop since early days of Covid-19 pandemic in Mar2020.

0
481

Nasdaq Biotech sank 6.5% in its worst weekly drop since early days of Covid-19 pandemic in Mar2020. Now down 19.2% from ATH. Benchmark gauge incl many comps that have yet to generate sales or profits & have been hit by rotation away from high-risk growth stocks in favor of value. h/t Holger Zschaepitz

Nasdaq Biotech sank 6.5% in its worst weekly drop since early days of Covid-19 pandemic in Mar2020.

Our Twitter for Quick Updates: Twitter Follow Us

This site uses Akismet to reduce spam. Learn how your comment data is processed.